featured
CDK 4/6 Inhibitors Are Associated With a High Incidence of Thrombotic Events in Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European journal of haematology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CDK 4/6 Inhibitors Are Associated With a High Incidence of Thrombotic Events in Women With Breast Cancer in Real-World Practice
Eur. J. Haematol. 2021 Feb 02;[EPub Ahead of Print], MT West, CE Smith, A Kaempf, TCL Kohs, R Amirsoltani, J Ribkoff, JL Choung, A Palumbo, Z Mitri, JJ ShatzelFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.